The Developmental History of the Gadolinium Chelates as Intravenous Contrast Media for Magnetic Resonance

被引：38
作者：
Runge, Val M. [1 ]
Ai, Tao [2 ]
Hao, Dapeng [3 ]
Hu, Xuemei [2 ]
机构：
[1] Univ Texas Med Branch, Dept Radiol, Galveston, TX 77555 USA
[2] Huazhong Univ Sci & Technol, Dept Radiol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China
[3] Qingdao Univ, Dept Radiol, Affiliated Hosp, Coll Med, Qingdao 266071, Peoples R China
来源：
INVESTIGATIVE RADIOLOGY | 2011年 / 46卷 / 12期
关键词：
gadolinium; magnetic resonance (MR); intravenous contrast media; NEPHROGENIC SYSTEMIC FIBROSIS; GD-EOB-DTPA; BRAIN-TUMOR ENHANCEMENT; HUMAN SKIN FIBROBLASTS; MAGNEVIST GADOPENTETATE DIMEGLUMINE; CENTRAL-NERVOUS-SYSTEM; HIGH-DOSE GADOTERIDOL; FOCAL LIVER-LESIONS; III CLINICAL-TRIAL; HUMAN BLOOD-PLASMA;
D O I：
10.1097/RLI.0b013e318237913b
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The developmental history of the gadolinium chelates, which spans 30 years, is described, focusing, in part, on the seminal work with each of the major agents in use today. By examining this history, insight is gained into important issues of efficacy and safety, with valuable lessons to be learned from the mistakes made during this period. An overview of physicochemical characteristics and chemical structures is also provided. The review concludes with a discussion of current research directions involving this field, which is that of the intravenous contrast media for magnetic resonance, in the past 5 years.
引用
收藏
页码：807 / 816
页数：10
相关论文
共 50 条
  • [31] Gadolinium Retention in Erythrocytes and Leukocytes From Human and Murine Blood Upon Treatment With Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging
    Di Gregorio, Enza
    Furlan, Chiara
    Atlante, Sandra
    Stefania, Rachele
    Gianolio, Eliana
    Aime, Silvio
    INVESTIGATIVE RADIOLOGY, 2020, 55 (01) : 30 - 37
  • [32] How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol
    Daldrup-Link, Heike E.
    Theruvath, Ashok J.
    Rashidi, Ali
    Iv, Michael
    Majzner, Robbie G.
    Spunt, Sheri L.
    Goodman, Stuart
    Moseley, Michael
    PEDIATRIC RADIOLOGY, 2022, 52 (02) : 354 - 366
  • [33] Nephrogenic systemic fibrosis and gadolinium-based contrast media
    Andrejak, Michel
    Thuillier, Delphine
    Lok, Catherine
    Gras-Champel, Valerie
    THERAPIE, 2007, 62 (02): : 169 - 172
  • [34] With or without? A retrospective analysis of intravenous contrast utility in magnetic resonance neurography
    Harrell, Alan D.
    Johnson, Daniel
    Samet, Jonathan
    Omar, Imran M.
    Deshmukh, Swati
    SKELETAL RADIOLOGY, 2020, 49 (04) : 577 - 584
  • [35] Gadolinium-based contrast media: one step beyond
    Manrique Rodriguez, Silvia
    Martinez Fernandez-Llamazares, Cecilia
    Gimenez Manzorro, Alvaro
    Duran Garcia, Esther
    Sanjurjo Saez, Maria
    EJHP PRACTICE, 2010, 16 (06): : 26 - 31
  • [36] Kinetic stabilities of gadolinium(III) chelates used as MRI contrast agents
    Brücher, E
    CONTRAST AGENTS I: MAGNETIC RESONANCE IMAGING, 2002, 221 : 103 - 122
  • [37] Anaphylaxis Induced by Magnetic Resonance Imaging (MRI) Contrast Media
    Rosado, Ana
    Gonzalez-Moreno, Ana
    Privitera-Torres, Martina
    Tejedor-Alonso, Miguel A.
    CURRENT TREATMENT OPTIONS IN ALLERGY, 2020, 7 (01) : 32 - 42
  • [38] Indication-related dosing for magnetic resonance contrast media
    Yuh, WTC
    Parker, JR
    Carvlin, MJ
    EUROPEAN RADIOLOGY, 1997, 7 (Suppl 5) : S269 - S275
  • [39] Indication-related dosing for magnetic resonance contrast media
    W. T. C. Yuh
    J. R. Parker
    M. J. Carvlin
    European Radiology, 1997, 7 : S269 - S275
  • [40] Cardiovascular effects of intravenous gadolinium administration to anaesthetized dogs undergoing magnetic resonance imaging
    Mair, Alastair R.
    Woolley, Jenny
    Martinez, Miguel
    VETERINARY ANAESTHESIA AND ANALGESIA, 2010, 37 (04) : 337 - 341
12345